We rank companies based on fund manager, research analyst and news sentiment

111 Inc


About: 111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.

Employees: 1,657

Funds holding %
of 6,474 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

21% more funds holding

Funds holding: 14 [Q3] → 17 (+3) [Q4]

0.04% more ownership

Funds ownership: 2.0% [Q3] → 2.04% (+0.04%) [Q4]

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

38% less capital invested

Capital invested by funds: $5.19M [Q3] → $3.24M (-$1.95M) [Q4]

Research analyst outlook

We haven’t received any recent analyst ratings for YI.

Financial journalist opinion